Literature DB >> 23629558

Community-based cardiovascular Risk Factors Intervention Strategies (CORFIS) in managing hypertension: A pragmatic non-randomised controlled trial.

W H H Low1, W Seet, Ramli A S, K K Ng, Jamaiyah H, S P Dan, C L Teng, V K M Lee, S S Chua, Faridah Aryani M Y, Karupaiah T, W S S Chee, P P Goh, Zaki M, T O Lim.   

Abstract

BACKGROUND: Hypertension is the number one cardiovascular risk factor in Malaysia. This study aimed to evaluate the effectiveness of a Community-Based Cardiovascular Risk Factors Intervention Strategies (CORFIS) in the management of hypertension in primary care.
METHODS: This is a pragmatic, non-randomized controlled trial. Seventy general practitioners (GPs) were selected to provide either CORFIS (44 GPs) or conventional care (26 GPs) for 6 months. A total of 486 hypertensive patients were recruited; 309 were in the intervention and 177 in the control groups. Primary outcome was the proportion of hypertensive patients who achieved target blood pressure (BP) of <140/90mmHg (for those without diabetes mellitus) and <130/80mmHg (with diabetes mellitus). Secondary outcomes include change in the mean/median BP at 6-month as compared to baseline.
RESULTS: The proportion of hypertensive patients who achieved target BP at 6-month was significantly higher in the CORFIS arm (69.6%) as compared to the control arm (57.6%), P=0.008. Amongst those who had uncontrolled BP at baseline, the proportion who achieved target BP at 6-month was also significantly higher in the CORFIS arm (56.6%) as compared to the control arm (34.1%), p<0.001. There was no difference in the patients who had already achieved BP control at baseline. There were significant reductions in SBP in the CORFIS arm (median -9.0mmHg; -60 to 50) versus control (median -2mmHg; -50 to 48), p=0.003; as well as in DBP (CORFIS arm: median -6.0mmHg; ranged from -53 to 30 versus control arm: median 0.0mmHg; ranged from -42 to 30), p<0.001.
CONCLUSIONS: Patients who received CORFIS care demonstrated significant improvements in achieving target BP.

Entities:  

Mesh:

Year:  2013        PMID: 23629558

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  12 in total

Review 1.  Molecular mechanisms underlying the antimetastatic activity of bufalin.

Authors:  Jie Wang; Yue Xia; Qingshong Zuo; Teng Chen
Journal:  Mol Clin Oncol       Date:  2018-03-21

2.  The effect of hypertension and diabetes management in Southwest China: a before- and after-intervention study.

Authors:  Xiaohua Liang; Jie Chen; Youxue Liu; Chunling He; Tingyu Li
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

3.  Effectiveness of the EMPOWER-PAR Intervention in Improving Clinical Outcomes of Type 2 Diabetes Mellitus in Primary Care: A Pragmatic Cluster Randomised Controlled Trial.

Authors:  Anis Safura Ramli; Sharmini Selvarajah; Maryam Hannah Daud; Jamaiyah Haniff; Suraya Abdul-Razak; Tg Mohd Ikhwan Tg-Abu-Bakar-Sidik; Mohamad Adam Bujang; Boon How Chew; Thuhairah Rahman; Seng Fah Tong; Asrul Akmal Shafie; Verna K M Lee; Kien Keat Ng; Farnaza Ariffin; Hasidah Abdul-Hamid; Md Yasin Mazapuspavina; Nafiza Mat-Nasir; Chun W Chan; Abdul Rahman Yong-Rafidah; Mastura Ismail; Sharmila Lakshmanan; Wilson H H Low
Journal:  BMC Fam Pract       Date:  2016-11-14       Impact factor: 2.497

4.  Short-term hypertension management in community is associated with long-term risk of stroke and total death in China: A community controlled trial.

Authors:  Zengwu Wang; Guang Hao; Xin Wang; Wen Wang; Weiwei Chen; Manlu Zhu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  A qualitative study on pharmacists' perception on integrating pharmacists into private general practitioner's clinics in Malaysia.

Authors:  Pui S Saw; Lisa Nissen; Christopher Freeman; Pei S Wong; Vivienne Mak
Journal:  Pharm Pract (Granada)       Date:  2017-09-02

6.  Modifiable lifestyle risk factors for stroke among a high risk hypertensive population in Greater Kampala, Uganda; a cross-sectional study.

Authors:  Mark Kaddumukasa; James Kayima; Jane Nakibuuka; Carol Blixen; Elisabeth Welter; Elly Katabira; Martha Sajatovic
Journal:  BMC Res Notes       Date:  2017-12-04

7.  Chronic care model in primary care: can it improve health-related quality of life?

Authors:  Faridah Md Yusof Aryani; Shaun Wen Huey Lee; Siew Siang Chua; Li Ching Kok; Benny Efendie; Thomas Paraidathathu
Journal:  Integr Pharm Res Pract       Date:  2016-01-19

8.  Risk Factors for Chronic Diseases and Multimorbidity in a Primary Care Context of Central Argentina: A Web-Based Interactive and Cross-Sectional Study.

Authors:  David E V Olivares; Frank R V Chambi; Evelyn M M Chañi; Winston J Craig; Sandaly O S Pacheco; Fabio J Pacheco
Journal:  Int J Environ Res Public Health       Date:  2017-03-02       Impact factor: 3.390

9.  Study protocol of EMPOWER participatory action research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care.

Authors:  Anis S Ramli; Sharmila Lakshmanan; Jamaiyah Haniff; Sharmini Selvarajah; Seng F Tong; Mohamad-Adam Bujang; Suraya Abdul-Razak; Asrul A Shafie; Verna K M Lee; Thuhairah H Abdul-Rahman; Maryam H Daud; Kien K Ng; Farnaza Ariffin; Hasidah Abdul-Hamid; Md-Yasin Mazapuspavina; Nafiza Mat-Nasir; Maizatullifah Miskan; Jaya P Stanley-Ponniah; Mastura Ismail; Chun W Chan; Yong R Abdul-Rahman; Boon-How Chew; Wilson H H Low
Journal:  BMC Fam Pract       Date:  2014-09-13       Impact factor: 2.497

10.  Assessment of hypertension chronic care model: Pacic application in Bosnia and Herzegovina.

Authors:  Natasa Pilipovic-Broceta; Nadja Vasiljevic; Jelena Marinkovic; Nevena Todorovic; Janko Jankovic; Irena Ostric; Dimitra Kalimanovska-Ostric; Maja Racic
Journal:  PLoS One       Date:  2018-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.